Replies to post #73681 on Muscle Pharm Corporation (MSLPQ)

[JimmyJams]

Seeking Alpha has a transcript of the call.

http://seekingalpha.com/article/3007126-musclepharms-mslp-ceo-brad-pyatt-on-q4-2014-results-earnings-call-transcript

It is basically worthless since they did not do a Q&A. All fluff about total year 2014.

[MacDaddy23]

Exactly what I was saying yesterday:

Current Assets > Current Liabilities

When management sees the bank account getting low they will physically not be able to spend like the drunken a-holes they have been (particularly in Q4). The market just told them that raising cash via equity will be too expensive and they have already tapped debt markets.

The company can weather this storm like they have every other storm they have created for themselves.

Consider this a great trading opportunity. By some shares super cheap -> sell those shares after a nice gain -> wait for real confirmation that management and the company are on a solid foot before trying to ride the stock to the (buyout) moon.

[PanchoJimenz]

I wrote about working capital a few days ago. People who don't know better just look at one thing and freak out; they don't understand the full scope of how companies operate.

On another note, you mentioned yesterday that you think that Q1 will be huge. Based on their guidance, I don't think that it will be. My guess is that they will do in the $45-$50 million range.

Another thing that I have not seen anyone mention came from their conference call. The CFO said that they paid $7.1 million for Biozone, which provided $12 million in revenue last year. With 10 weeks into the year, Biozone has provided more than $7.1 million this year.

"BioZone Labs, which we acquired in January 2014, accounted for $12.3 million of our sales growth for the year and $2 million in the 2014 fourth quarter. Recall we did acquire BioZone in the first quarter of this year for $7.1 million in stock, and that we have already surpassed that mark in revenue for this year."